Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Overview Trevena Inc. (Nasdaq: TRVN) is set to present tomorrow February 12 at 9:15 EST at the 21st Annual BIO CEO & … [Read more...] about TRVN to Present at BIO & CEO Conference
Search Results for: Trvn
Introduction Trevena Inc. (Nasdaq: TRVN) spiked 119% from the $.5 range to $1.19 on January 28th. The catalyst being positive regulatory updates from the FDA Type A meeting minutes. In a … [Read more...] about 2019 Should Be A Good Year For TRVN, But What’s Next?
Leave a comment and click here to sub for MS Equity Analysis and Swing Moves. Good Morning! We hope you all are enjoying your early morning trading! Today, three companies we … [Read more...] about Morning Update-Form 13G’s On Deck!
Overview Swing Trading is a trading strategy that involves buying a stock at a lower price and selling it at a higher price over a short period of time. Return on investment targets ranges from … [Read more...] about Swing Trading a Biotech Stock
Premarket today TRVN has dropped almost 70% off news that the FDA believes their drug Oliceridine has high abuse potential. With ACRX's ADCOM this week too I can understand the hesitation to … [Read more...] about ACRX Stay the course
Question by deadpool from StockTwits: Q: "how do you feel about ACRX price action today seems like just a red market is tearing everything down. i am hopeful we get back up to 3.30s next week" Thanks … [Read more...] about A Question about ACRX price decline after Dsuvia approval
AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) Swing Thesis ACRX traded last around $2.90 and has entered oversold territory. It has a FDA advisory committee meeting (ADCOM) scheduled for 10/12/2018 and a … [Read more...] about SWING ALERT
Introduction Recro Pharma (NASDAQ: REPH) engages in the research and development of non-opioid therapeutics for the treatment of acute postoperative pain. REPH is currently developing three … [Read more...] about $REPH – Recro Pharma, PDUFA Swing Trade
EquityEntry5/28/19Gain/Loss (%)RatingPrice Target (12 mo)ADMA Biologics (ADMA)$2.98$4.46+49.7Buy$12Regenxbio (RGNX)$45.86$48.92+6.7Buy$100Galectin Therapeutics (GALT)$2.30$4.11+78.7Buy$8Seattle … [Read more...] about MS Portfolio
Whenever a team member scores a win we post it here on the wall of GAINS. Let's get this bread! Charts were made on TradingView Galectin Therapeutics (Nasdaq: GALT) Entered at $3.80 and … [Read more...] about Wall of Gains